3 results about "Orthosiphon stamineus" patented technology

The invention relates to the technical field of traditional Chinese medicine pharmacy, and discloses a traditional Chinese medicine composition for reducing uric acid and application thereof, and the traditional Chinese medicine composition comprises the following components in parts by mass: 15-20 parts of ash bark, 20-25 parts of clerodendranthus spicatus, 18-22 parts of astragalus membranaceus, 12-15 parts of prepared polygonum multiflorum, 15-18 parts of rhizoma smilacis glabrae, 8-10 parts of ligusticum wallichii, 10-12 parts of roasted rhizoma atractylodis macrocephalae and 10-15 parts of salt-fried semen plantaginis. The preparation method comprises the three steps of segmented extraction, sustained-release pellet forming and preparation forming. The traditional Chinese medicine composition disclosed by the invention has the high-efficiency performance of reducing uric acid, protecting healthy qi and achieving long-term effect, and can regulate and control a uric acid metabolic pathway in a multi-target manner; the product can be widely applied to the fields of products for treating primary hyperuricemia and gout in a sustained-release period, products for improving hyperuricemia metabolic syndrome, health-care tea for hyperuricemia and high-risk people, gel products for relieving red, swollen and heat pain of joints in an acute attack period of gout and the like, and the preparation process is controllable and easy to industrialize.

The invention relates to the technical field of traditional Chinese medicines, in particular to a foundation-consolidating and life-prolonging pill for improving frequent urination at night and a preparation method of the foundation-consolidating and life-prolonging pill. The invention discloses a foundation strengthening and life prolonging pill for improving frequent micturition at night. The traditional Chinese medicine composition comprises the following components in parts by weight: 3-12 parts of ginseng, 5-15 parts of Chinese yam, 3-12 parts of dogwood, 2-14 parts of akebiaquinata, 3-10 parts of exocarpium benincasae, 2-10 parts of pericarpium arecae, 1-8 parts of semen boitae, 3-12 parts of radix achyranthis bidentatae, 1-7 parts of deer-horn glue, 1-7 parts of tortoise-plastron glue, 5-16 parts of pyrrosia lingua, 0.5-5 parts of liquorice, 3-10 parts of morinda officinalis, 4-15 parts of mantis egg-case, 3-10 parts of fructus alpiniae oxyphyllae, 6-20 parts of fructus rosae laevigatae, 6-20 parts of raspberry and 6-20 parts of The foundation-consolidating and life-prolonging pill does not cause pathological damage to drug metabolism visceral liver tissue, urine metabolism and regulation of visceral kidney, adrenal gland and bladder tissue. According to a high-dose group of the foundation strengthening and life prolonging pills, the urination latency period can be remarkably prolonged, the urine volume and weight ratio and the total excretion rate can be reduced, the urination latency period of the foundation strengthening and life prolonging pill is prolonged to 47.88 min from 34.38 min, the urine volume and weight ratio is reduced to 29.86 mL / kg from 44.81 mL / kg, and the total excretion rate is reduced to 62.86% from 81.37%.

The degradation inhibitor of the ultraviolet absorber disclosed herein comprises a plant extract belonging to the genus *Orthosiphon stamineus* of the Lamiaceae family, which can inhibit the decrease in ultraviolet absorption caused by exposure to ultraviolet light. The ultraviolet absorber is preferably 2-[4-(diethylamino)-2-hydroxybenzoyl]hexyl benzoate. The plant belonging to the genus *Orthosiphon* of the Lamiaceae family is preferably *Orthosiphon stamineus* Bent.